Dean M Calhoun Cih public
[search 0]
More

Download the App!

show episodes
 
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email affygility@gmail.com or call our listener voicemail line at 206-984-3214.
 
Loading …
show series
 
BioPharma EH&S Podcast Episode No. 28. Hello everybody and welcome back to another Episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safe…
 
Occupational Toxicology and Occupational Medicine - Where are they the same and where are they different? In this episode of the BioPharma EHS Podcast, Dean M. Calhoun, President and CEO of Affygility Solutions hosts a discussion between Dr. Mark Cunningham-Hill, President of Worldwide Health Consulting LLC and Dr. Frank Richardson, Principal Toxic…
 
In Episode #24 of the Biopharma EHS podcast, Dean M. Calhoun, CIH discusses with Dr. Joe Nieusma, Senior Occupational Toxicologist for Affygility Solutions, the "Mystery of Cytotoxic Compounds." For multi-product pharmaceutical manufacturing facilities, this often a controversial topic since many people believe that cytotoxic compounds require dedi…
 
In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions interviews Kevin Rosenthal of Pharmatek Laboratories. During the interview we discuss handling potent compounds, potent compound safety, and occupational control banding. Dean Calhoun also responds to the frequently asked question, "What ty…
 
In this episode of the Biopharma EHS Podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions, interviews Ms. Stephanie Wilkins, President of PharmaConsult US, on the subject of Risk-MaPP, ADEs and PDEs: Their importance to multi-product pharmaceutical manufacturing facilities. Risk-MaPP stands for Risk-Based Manufacture of Pharmace…
 
BioPharma EH&S Podcast Episode No. 20 Hello everybody and welcome back to another Episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safet…
 
In this podcast, Dean M. Calhoun of Affygility Solutions discusses four key technologies or trends that will have a significant impact on the pharmaceutical industry for the next 100 years. These trends include: the development of medicines in space, the Internet of Things, the Maker movement, and the use of Big Data tools. He will also discuss tak…
 
In this presentation, Dean M. Calhoun, CIH, with certification in industrial hygiene by the American Board of Industrial Hygiene (ABIH) discusses the key concepts and principles that need to be considered when auditing biotechnology and pharmaceutical facilities for potent compound safety issues. His talk was presented at the World Highly Potent Ac…
 
Nanotechnology and the Pharmaceutical Industry - an interview with Don Ewert of OSO Biopharmaceuticals. Hello everybody and welcome back to another episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biophar…
 
Containment Validation and Surrogate Monitoring In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions discusses the following topics: A review of Episode no. 16 of the Biopharma EHS podcast. In that episode, Dean M. Calhoun, President and CEO of Affygility Solutions, and Dr. Joe Nieusma, Sr. O…
 
In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks. Items covered include: Review of the last podcast What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound We provide examples o…
 
BioPharma EHS Podcast Episode No. 15 - Thursday, April 21, 2011. We have a lot of great things to talk about. But before I tell you what were going to discuss I should mention that the twitter hashtag for today’s podcast is #biopharma15. For those of you that don’t know how to use Twitter and believe it’s useless, you should really try it out. OSHA…
 
Our main topic for today is the Young Guns of Environmental, Health and Safety [listen to podcast for details] Alright, that does it for our main topic, let’s now talk about some upcoming events. First I should mention, that coming up next week, we have several new webinars starting and you should look at our schedule at Affygility.com. These webin…
 
In this podcast, Dean Calhoun of Affygility Solutions discusses Social Media and Environmental, Health and Safety The twitter hashtag for today’s podcast is #socialehs First, I’ll briefly cover what we talked about last time in episode number 12 Then I will cover our main topic for today, which is the use of Social Media in Environmental, Health an…
 
BioPharma EH&S Podcast Episode No. 12. Saturday, March 5th, 2011 and we have so much to talk about today, so I’m going to get right into it. First off, I’ll briefly cover what we talked about last time in episode number 11 Main topic for today :“Creeping Featurism in Environmental, Health and Safety software”, which I’m quite certain sure will stir…
 
BioPharma EH&S Podcast Episode #11 Discuss: The Evolution of Environmental, Health and Safety Compliance and Operational Risk Management Software Upcoming Events and Happenings of Importance to Environmental, Health and Safety professionals in the BioPharma industry. Hello everybody and welcome back to the Biopharma EH&S Podcast, Episode #11, it's …
 
BioPharma EH&S Podcast Episode No. 10 Note: This is the abbreviated script of the podcast, for the more detailed version go to http://potentcompoundsafety.com/?p=642 Cover what we talked about last time in episode number 9 Then I will cover our main topic for today, which is “Industrial hygiene in the pharmaceutical industry.” Discuss upcoming even…
 
Biopharma EHS Podcast Episode #9 Opening So for today, first off, I'll mention what we discussed last time, then we I'll cover our main topic for today - which is how to be a road warrior of environmental, health and safety, and then finally, I will mention important upcomings and happenings that are applicable to environmental, health and safety p…
 
Biopharma EHS Podcast Episode #8 Oh yay everybody, that’s right.that’s right..how are yay? Folks it’s Tuesday, February 1st, 2011 and that’s right, we’re back we’re back for another episode of the BioPharma EH&S podcast. So what’s on our agenda for today? Our agenda for today on the Biopharma EH&S podcast is the following. AS ALWAYS I’ll briefly co…
 
Management Commitment and Involvement - How to obtain it and sustain it for your EHS Program. Introduction. Review last time. Main topic: "Management Commitment – how to obtain and sustain it.” Upcoming events and happenings of importance to environmental, health and safety professionals in the BioPharma Industry. Important announcement to talk abo…
 
I2P2 and GHS - important OSHA regulatory issues for 2011. In this episode of the BioPharma EHS podcast, Dean M. Calhoun, CIH - President and CEO of Affygility Solutions discusses two of OSHA's regulatory issues for the calendar year 2011 that will effect the biotechnology and pharmaceutical industry. The first issue is OSHA's Injury and Illness Pre…
 
In this episode of the BioPharma EHS Podcast, the top 10 OSHA violations in the biotechnology and pharmaceutical industry are discussed by Dean M. Calhoun, CIH, President and CEO of Affygility Solutions. These common violations include the respiratory protection standard, hazard communication, lockout/tagout, machine guarding, electrical, walking s…
 
Occupational health and safety never takes a vacation. In this episode of the BioPharma EHS Podcast, Dean M. Calhoun of Affygility Solutions discusses the problem with having an environmental, health and safety program that relies heavily on one person, and he offers advice on how to build a sustainable program that has bench strength. Other announ…
 
Call 206-904-3214 for our listener voicemail question and feedback line. In this episode, Dean M. Calhoun, President and CEO of Affygility Solutions discusses how to become an environmental, health and safety rockstar, and has an interview with Joseph Logan, President of Global Advisors. In this interview, Joseph discusses the amount of waste that …
 
Call 206-984-3214 for our listener voicemail question and feedback line. This line is open 24 hours per day. Questions regarding potent compound safety, occupational toxicology, industrial hygiene, containment validation, compliance management software, etc. in the biotechnology, pharmaceutical, and medical device industry are appropriate. Please l…
 
BioPharma EH&S podcast episode 1December 6th, 2010Hello everyonewelcome to the inaugural episode of BioPharma EH&S podcast, my name is Dean Calhoun and this IS THE podcast where I will discuss environmental, health and safety issues affecting the BioPharma Industry.I’m here to help answer any questions you may have regarding:* potent compound safet…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login